The US develops a vaccine to deal with a new CoV strain
The US develops a vaccine to deal with a new CoV strain news Debbie Elrick 29 Jan 2021 (89) The US company Novavax developed the Covid-19 vaccine that was 89.3 percent effective in the Phase Three trial in the UK, but at a lower rate with the South African strain. Novavax's two-injected NVV-CoV2373 vaccine is also highly effective with the new CoV variant recently discovered in the UK. Covid-19 vaccine from the American biotechnology company Novavax Photo: Reuters ...
Jessica M Bruce
Jef Gaspar Sabrozo
Ammar Raza
Aimee Hogg
Arani Saha
Tammy Jane Cunningham
Marina Egorova
Noelle Holloman
Graham Brown
Sarah Guerra
Amanda Hudson
Kalpesh D Jain
Stacy Lynn Farley
Sharon Perkins
Lewis Garner
Katie Lopez
Mercy Atienza Pillone
Amber Elizabeth Lewis